MOYOM has achieved EU MDR certification for its APHRANEL® regenerative aesthetics technology and established a scientific collaboration with Expert2Expert (E2E) to support clinical research, physician education, and evidence generation across Europe.
Get the latest in Medical Aesthetics in our weekly ValuraNova Pulse. Sign up now.
The certification, granted by BSI UK, confirms that APHRANEL® meets European standards for quality, safety, and clinical performance, enabling the company to advance its international expansion. The partnership with E2E, led by aesthetic surgeon Dr. Patrick Trévidic, will focus on anatomy research, clinical studies, medical education, and scientific publications to strengthen the clinical foundation of regenerative aesthetics.
“Obtaining market access is only the first challenge. Earning physicians’ confidence is the one that matters most,” said Guangming Lin, Founder and CEO of MOYOM.
Read the full story here.
